Individual Investors Are Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.'s (SHSE:603168) Biggest Owners and Were Hit After Market Cap Dropped CN¥372m

Simply Wall StDec 19, 2024 18:12 ET

Zhejiang Shapuaisi Pharmaceutical Secures Clinical Trial Approval for Eye Drops

MT NewswiresDec 10, 2024 03:05 ET

Shapuaisi Pharmaceutical Shareholders Plan to Reduce Stakes; Shares Down 10%

MT NewswiresNov 22, 2024 02:06 ET

Revenues Not Telling The Story For Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (SHSE:603168) After Shares Rise 38%

Simply Wall StOct 23, 2024 18:10 ET

Shapuaisi Pharmaceutical Gets China Approval for Eye Drops Clinical Trial

MT NewswiresOct 11, 2024 04:26 ET

Zhejiang Shapuaisi PharmaceuticalLtd (SHSE:603168) Shareholders Are up 16% This Past Week, but Still in the Red Over the Last Year

Simply Wall StOct 2, 2024 21:01 ET